PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, United Kingdom.\', \'Statistics, Modelling and Economics Department, UK Health Security Agency, London, United Kingdom.\', \'Paediatric Infectious Diseases Research Group, St. George\'s University of London, London, United Kingdom.\', \'Brondesbury Medical Centre, Kilburn, London, United Kingdom.\', \'Sero-Epidemiology Unit, UK Health Security Agency, Manchester, United Kingdom.\', \'Virus Reference Department, UK Health Security Agency, London, United Kingdom.\', \'Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.2807/1560-7917.ES.2022.27.1.2101114
?:hasPublicationType
?:journal
  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
is ?:pmid of
?:pmid
?:pmid
  • 34991777
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Serological responses to COVID-19 Comirnaty booster vaccine, London, United Kingdom, September to December 2021.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all